Status:
COMPLETED
Multi-Center Registry Trial of EXCEL Biodegradable Polymer Drug-Eluting Stent
Lead Sponsor:
JW Medical Systems Ltd
Conditions:
AMI
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The trial aims to evaluate 12-month long-term efficiency of Excel stent in the treatment of coronary heart disease and inhibition of restenosis after coronary artery stenting as well as a 12 months' l...
Eligibility Criteria
Inclusion
- Patient who should be full fill the criteria of using Excel stent.
- Each included patient should allowed to use Excel stent.
- Complete revascularization can be achieved through one invasive operation.
Exclusion
- Patient do not suitable to use Excel stent, for example, not tolerant to anti-platelet drug or undergo cardiac/non-cardiac surgery recently.
- Patient with multiple branch lesions, thus the single Excel stent cannot resolve the condition.
- NYH Cardiac functional grading\>3 or Echocardiography LVEF\<0.3.
- Patient with complete revascularization cannot be resolved by one operation.
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
2077 Patients enrolled
Trial Details
Trial ID
NCT00331578
Start Date
June 1 2006
End Date
December 1 2006
Last Update
January 21 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.